Thymosin-α1 for repeated IVF failure
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You have had at least 2 failed embryo transfers using embryos that were tested and found to be genetically normal.
- You and your partner have normal chromosomes.
- Your uterine cavity looks normal on imaging tests.
- You do not have antiphospholipid antibodies (a type of immune protein that can affect pregnancy).
- Your thyroid and prolactin levels are within normal limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can improve the success of frozen embryo transfer in women who have had at least two failed attempts with good embryos. It may help if you're planning another frozen embryo transfer soon.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This trial tests whether a traditional Chinese medicine pill called Zishen Yutai can help with repeated implantation failure—when embryos fail to implant during in vitro fertilization (IVF). You would take this pill before a frozen embryo transfer to see if it improves your chances of pregnancy.
This study tests whether checking the timing of the uterine lining (endometrium) before transferring an embryo can help women who have had multiple failed embryo transfers. It aims to improve the chance of a successful pregnancy for women under 35 with no known cause for their infertility.
This trial studies whether adding acupuncture during embryo transfer and hormone treatment can improve pregnancy outcomes for women who have had repeat IVF implantation failures with no known cause. It may help your chance of clinical pregnancy when you transfer good-quality frozen embryos.
This Phase 3 study tests certolizumab to help people with repeated embryo transfer failures achieve a clinical pregnancy. It may be an option if your infertility has no known cause and you meet the other study checks.
Hear when a new Recurrent Implantation Faliure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.